Epstein Secrets

ange. Please contact your Morgan Stanley representative for more details. A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement b

ation or qualification under the securities laws of any such state or jurisdiction. A prospectus relating to these securities may be obtained from Morgan Stanley & Co. LLC, Attn: Pros ectus De artment, 180 Varick Street, 2nd Floor, New York, NY 10014 (Tel: 866-718-1649), Email: ; Not for distribution to private custo

ange. Please contact your Morgan Stanley representative for more details. A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement b

ration or qualification under the securities laws of any such state or jurisdiction. A prospectus relating to these securities may be obtained from Morgan Stanley & Co. LLC, Attn: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014 (Tel: 866-718-1649), Email: Not for distribution to private custom

ort on Form 10-Q for the quarterly period ended September 30. 2015. to co a Ce3 which are incorporated herein by reference. ca os co a Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these a= >. securities or passed upon the accuracy or adequacy of this prospectus

SSIBLE EFFECTS OF CHANGES IN UNITED STATES OR OTHER TAX LAWS. S-28 EFTA00690318 UNDERWRITING Merrill Lynch, Pierce, Fenner & Smith Incorporated, Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, UBS Securities LLC and Wells Fargo Securities, LLC are acting as representatives of the underwriters named below. Subje

offering price. less the underwriting discount. within 30 days from the date of this prospectus supplement solely to cover over-allotments. None of the Securities and Exchange Commission, any state securities commission, the Registrar of Companies in Bermuda, the Bermuda Monetary Authority or any other regulatory body has approved or

ons set forth in an underwriting agreement between us and the undenvriters named below, for whom Merrill Lynch, Pierce, Fenner & Smith Incorporated, Morgan Stanley & Co. LLC and UBS Securities LLC are acting as representatives (the "Representatives"), we have agreed to sell to them, and the underwriters have severally a

and • other risks detailed in our Annual Report on Form 10-K for the year ended December 31, 2015 and from time to time in our other filings with the Securities and Exchange Commission ("SEC"). We describe some of these risks and uncertainties in greater detail under the caption "Risk Factors" above, beginning on page 6 of the acc

customary financial practice, in pricing a new issue of corporate debt securities maturing on , 2021. "Independent Investment Banker- means one of Morgan Stanley & Co. LLC, Merrill Lynch. Pierce. Fenner & Smith Incorporated. UBS Securities LLC, Wells Fargo Securities, LLC, and their respective successors, appointed by

"Risk Factors" beginning on page S•6 to read about factors you should consider before buying the depositary 'S a. shares. == fa ace — o Neither the Securities and Exchange Commission nor any slate securities commission has approved or disapproved of these di ..... 0) ... = .- securities or passed upon the adequacy or accurac

NFLICTS OF INTEREST) The Bank of New York Mellon Corporation and Citigroup Global Markets Inc., Merrill Lynch, Pierce. Fenner & Smith Incorporated, Morgan Stanley & Co. LLC, UBS Securities LLC and BNY Mellon Capital Markets, LLC, as the representatives of the underwriters, have entered into an underwriting agreement dat